Shaheenah Dawood/LinkedIn
Sep 9, 2025, 02:03
Shaheenah Dawood: Addition of Osimertinib to Neoadjuvant Chemotherapy
Shaheenah Dawood, Consultant Medical Oncologist at Mediclinic Middle East, shared a post on LinkedIn:
“neoADAURA
Presented at ASCO, and now we see the ctDNA clearance data.
Addition of Osimertinib to neoadjuvant chemo increases MRD clearance compared to chemo alone.
Unfortunately, no arm of OSI alone here to see if chemo is actually required in the neoadjuvant setting!”
More from Shaheenah Dawood on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 9, 2025, 02:03
Sep 9, 2025, 01:48
Sep 9, 2025, 01:43
Sep 9, 2025, 00:59
Sep 9, 2025, 00:46
Sep 8, 2025, 17:37
Sep 8, 2025, 16:57